Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomePreferred Dividend PaymentsProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Benitec Biopharma (BNTC) Shares Outstanding (Weighted Average): 2019-2025

Historic Shares Outstanding (Weighted Average) for Benitec Biopharma (BNTC) over the last 7 years, with Jun 2025 value amounting to $25.6 million.

  • Benitec Biopharma's Shares Outstanding (Weighted Average) rose 173.29% to $25.6 million in Q2 2025 from the same period last year, while for Mar 2025 it was $23.5 million, marking a year-over-year increase of 804.61%. This contributed to the annual value of $25.6 million for FY2025, which is 173.29% up from last year.
  • Benitec Biopharma's Shares Outstanding (Weighted Average) amounted to $25.6 million in FY2025, which was up 173.29% from $9.4 million recorded in FY2024.
  • In the past 5 years, Benitec Biopharma's Shares Outstanding (Weighted Average) registered a high of $25.6 million during FY2025, and its lowest value of $462,024 during FY2021.
  • Its 3-year average for Shares Outstanding (Weighted Average) is $12.2 million, with a median of $9.4 million in 2024.
  • Data for Benitec Biopharma's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 511.17% (in 2021) over the last 5 years.
  • Benitec Biopharma's Shares Outstanding (Weighted Average) (Yearly) stood at $462,024 in 2021, then rose by 4.04% to $480,688 in 2022, then soared by 242.42% to $1.6 million in 2023, then surged by 469.12% to $9.4 million in 2024, then skyrocketed by 173.29% to $25.6 million in 2025.